To know the impact of COVID-19 On Sarcopenia Treatment Market Size By Supplement Type (Protein Supplement, Vitamin D Supplement, Vitamin B12 Supplement, Others), By Distribution Channel (Pharmacies, Online, Hypermarket & Supermarket, Others) Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 – 2027 Market
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027
Brandessence Market Research has published a new report title “Sarcopenia Treatment Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027”. The global sarcopenia treatment market is expected to grow at significant growth rate due to number of driving factors.
The global demand for sarcopenia treatment market in terms of revenue was worth of USD 262.9 Million in 2020 and is expected to reach USD 377.6 Million in 2027, growing at a CAGR of 5.87% from 2021 to 2027.
Scope of Sarcopenia Treatment Market:
Sarcopenia is a type of muscle loss (muscle atrophy) that occurs with aging and/or immobility. It is characterized by the degenerative loss of skeletal muscle mass, quality, and strength. The rate of muscle loss is dependent on exercise level, co-morbidities, nutrition and other factors. Sarcopenia can lead to reduced quality of life and disability. It involves the loss of muscle mass and strength due to natural aging process. This condition affects the gait and overall ability of body to perform normal tasks. According to International Osteoporosis Foundation (IOF), the muscle loss starts from the age of 40. The major causes of sarcopenia could be sedentary lifestyle, malnutrition and unhealthy food intake. As the prevalence of sarcopenia is high among the older population, many manufacturers are focusing on research and development of drugs to treat sarcopenia.
Covid-19 has witnessed a positive impact on global sarcopenia treatment market as increasing number of cases of sarcopenia as a deterioration of muscle mass and function (more likely in older populations) as well as increase in body fat due to lockdowns restrictions. Due to limitations and distancing policy during Codid-19, there is a reduction in physical activity & changes in dietary intakes that have the potential to accelerate sarcopenia.
The study provides a crucial view of global sarcopenia treatment market by segmenting the market based on supplement type, distribution channels and region & country level. Based upon supplement type, the market is segmented into protein supplement, vitamin B12 supplement, vitamin D & calcium supplement and others. Based upon distribution channels, the market is segmented into hospital pharmacy, online pharmacy and retail pharmacy. The regions covered in global sarcopenia treatment market are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, global sarcopenia treatment market is sub divided into U.S., Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Brazil, Mexico, GCC, Africa, etc.
Global Sarcopenia Treatment Market: Market Player Analysis
- Abbott Laboratories
- Nestle S.A.,
- Pfizer Inc.,
- Sanofi S.A.
Geriatric population suffering from cancer, diabetes, and osteoporosis have higher risk of developing sarcopenia. The rapidly ageing society requires a proven, cost effective, accessible and sustainable approach to prevent and treat age-related diseases effectively. Thus, increasing geriatric population is expected to be contributing to the global sarcopenia treatment market growth. According to World Population Prospects 2019 report; by 2050, one in six people in the world will be over the age of 65, up from one in 11 in 2019. There were 703 million persons aged 65 years or over in the world in 2019. The number of older persons is projected to double to 1.5 billion in 2050. Globally, the share of the population aged 65 years or over increased from six percent in 1990 to nine percent in 2019. That proportion is projected to rise further to 16 per cent by 2050, so that one in six people in the world will be aged 65 years or over. Over the next three decades, the global number of older persons is projected to more than double, reaching over 1.5 billion persons in 2050. Additionally, increasing investment in research and development to develop more effective therapies to treat Sarcopenia is expected to drive the sarcopenia treatment market growth. For instance; on March 1st, 2018; BIOPHYTIS demonstrated results of Sarconeos (BIO101) for treating sarcopenia, and announced patient enrolment for the SARA-INT international clinical study, at the 8th International Conference on Frailty & Sarcopenia Research (ICFSR). BIOPHYTIS, announced that it will present four posters and will give two oral presentations in the treatment of Sarcopenia at the 8th International Conference on Frailty & Sarcopenia Research. These results demonstrate the strong potential of Sarconeos (BIO101) in the treatment of Sarcopenia and confirm the relevance of the SARA-INT international clinical study, in which the first patient will be enrolled in the coming weeks. Furthermore, increasing R&D activities by the manufacturers for the development of new nutrition supplements is also expected to drive the sarcopenia treatment market in upcoming years.
The supplement type segment of sarcopenia treatment market is dominated by Protein Supplement with the largest market share of 43.80% in 2020. The distribution channels segment of sarcopenia treatment market report is dominated by Pharmacies segment by capturing the largest market of 41.54 % in year 2020.
The global Sarcopenia Treatment market research reports segments as follows:
By Supplement Type
- Protein Supplement
- Vitamin D Supplement
- Vitamin B12 Supplement
By Distribution Channel
- Hypermarket & Supermarket
Geographically, North America region is expected to dominate in the global sarcopenia treatment market. This is due to the presence of developed healthcare facilities and technological advancements, the prevalence of sarcopenia is high among old age population in this region. For instance; as per the Population Reference Bureau, the number of Americans ages 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060, and the 65-and-older age group’s share of the total population will rise from 16% to 23%. About 45% of older adults in the United States are affected by sarcopenia. In addition, there is a considerable economic burden of related healthcare expenditures for sarcopenia in the United States which is estimated to be USD 18.5 billion annually. The excess healthcare expenditures were $860 for every sarcopenia man and $933 for every sarcopenia woman. A 10% reduction in sarcopenia prevalence would result in savings of $1.1 billion (dollars adjusted to 2000 rate) per year in U.S. healthcare costs.
Asia Pacific region is expected to witness a significant growth in the global Sarcopenia market. This is due to the increasing geriatric population, increased research activities, and awareness in developing countries such as India and China. For instance; according to UNFPA report, the number of older people in the Asia-Pacific region is rising at an unprecedented rate and it is at the forefront of the global phenomenon of population ageing. By 2050, one in four people in Asia and the Pacific will be over 60 years old. The population of older persons (aged over 60) in the region will triple between 2010 and 2050, reaching close to 1.3 billion people.
Increasing Prevalence of Sarcopenia coupled with the Growing Geriatric Population, Rising Adoption of Vitamins and Dietary Supplements among Ageing Population, Growing Number Research and Development Activities to Develop More Innovative Treatment of Sarcopenia are Some of the Major Factors Driving the Market Growth
The increasing prevalence of the geriatric population and the growing number of cases of sarcopenia among the old age population are the major factors driving the demand of the sarcopenia treatment. Sarcopenia is predominantly a geriatric condition, with a gradual loss of skeletal muscle mass and a loss of muscle function. It is one of the leading health issues in the older adults, and it increases disability risk, falls as well as injuries related to falls, hospitalization, limitation of independence, and mortality. Nowadays, the number of sarcopenia cases in the geriatric population is increasing day by day and it is a big concern for different countries. For example; there are currently over 703 million people worldwide above the age of 65 years. With a gradual loss of skeletal muscle mass and a loss of muscle function the problem of sarcopenia is increasing in the geriatric population. According to the World Health Organization; by 2050; the world’s population aged 60 years and above is expected to reach 2 billion from 900 million in 2015. Moreover, the conferences, meetings held by the foundations help to expand and share the knowledge and information about sarcopenia treatment which will, in turn, drives the growth of the sarcopenia treatment market. For instance; the U.S. Food and Drug Administration held its public meeting on Patient-Focused Drug Development for sarcopenia in April 2017. The focus of the meeting was to acquire patient perspectives on symptoms and the daily impacts of their condition. The loss of muscle tissue may progress more rapidly when a person reaches their 60s and 70s.
Key Benefits for Global Sarcopenia Treatment Market Report:
- Global Sarcopenia Treatment Market report covers in-depth historical and forecast analysis.
- Global Sarcopenia Treatment Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
- Global Sarcopenia Treatment Market report helps to identify opportunities in marketplace.
- Global Sarcopenia Treatment Market report covers extensive analysis of emerging trends and competitive landscape.
Sarcopenia Treatment Market By Regional & Country Level:
- Southeast Asia
Middle East and Africa
- Rest of Middle East and Africa
Frequently Asked Questions (FAQ) :
Interested in this report?
Sarcopenia Treatment Market By Supplement Type, Distribution Channel Analysis Report, Regional Outlook to 2027
Sarcopenia Treatment Market Size By Supplement Type (Protein Supplement, Vitamin D Supplement, Vitamin B12 Supplement, Others), By Distribution Channel (Pharmacies, Online, Hypermarket & Supermarket, Others) Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 – 2027
Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Brandessence market research actively tracks, monitors, and analyses key industry trends in real-time via B2B surveys in 60 + countries and territories.